World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
34523
World Ranking
7725
National Ranking
4019

Overview

Phil Skolnick is affiliated with Opiant Pharmaceuticals in the United States and specializes in medical research related to opioid use and overdose treatment. Their scholarly output includes 30 publications focused within the broader field of Medicine, with specific expertise in Public Health, Environmental and Occupational Health, Anesthesiology and Pain Medicine, Emergency Medicine, Pharmacology, and Physiology.

The scientist's main research topics encompass opioid use disorder treatment, pain management and opioid use, anesthesia and sedative agents, poisoning and overdose treatments, cardiac arrest and resuscitation, treatment of major depression, and pain mechanisms and treatments. These topics reflect a concentrated investigation into both the clinical and pharmacological aspects of opioid-related health crises and pain intervention strategies.

Phil Skolnick's recent papers include the following:

  • Treatment of overdose in the synthetic opioid era, 2021, Pharmacology & Therapeutics
  • Countermeasures for Preventing and Treating Opioid Overdose, 2020, Clinical Pharmacology & Therapeutics
  • Pharmacokinetic Properties of an FDA-approved Intranasal Nalmefene Formulation for the Treatment of Opioid Overdose, 2023, Clinical Pharmacology in Drug Development
  • Reversal of Opioid-Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone, 2024, The Journal of Clinical Pharmacology
  • Comparison of intranasal naloxone and intranasal nalmefene in a translational model assessing the impact of synthetic opioid overdose on respiratory depression and cardiac arrest, 2024, Frontiers in Psychiatry

Frequent coauthors collaborating with Phil Skolnick include:

  • Céline M. Laffont
  • Prasad Purohit
  • Christian Heidbreder
  • Mark J. Ellison
  • Nash Delcamp

Their work appears mainly in journals such as Clinical Pharmacology & Therapeutics, Clinical Pharmacology in Drug Development, Frontiers in Psychiatry, Pharmacology & Therapeutics, and The Journal of Clinical Pharmacology. Clinical Pharmacology & Therapeutics and Clinical Pharmacology in Drug Development have each published multiple studies featuring Phil Skolnick, indicating recurrent involvement in these fields.

Best Publications

  • Receptors for the age of anxiety: pharmacology of the benzodiazepines

    John F. Tallman;Steven M. Paul;Phil Skolnick;Dorothy W. Gallager

  • Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

    Ramon Trullas;Phil Skolnick

  • Ethanol stimulates gamma-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes.

    Peter D. Suzdak;Rochelle D. Schwartz;Phil Skolnick;Steven M. Paul

  • A selective imidazobenzodiazepine antagonist of ethanol in the rat

    Peter D. Suzdak;John R. Glowa;Jacqueline N. Crawley;Rochelle D. Schwartz

  • Glutamate and Depression

    Ian A. Paul;Phil Skolnick

  • Differences in fear motivated behaviors among inbred mouse strains.

    Ramon Trullas;Phil Skolnick

  • Antidepressants for the new millennium.

    Phil Skolnick

  • Glutamate-based antidepressants: 20 years on

    Phil Skolnick;Piotr Popik;Piotr Popik;Ramon Trullas

  • Benzodiazepine receptor-mediated experimental "anxiety" in primates.

    Philip T. Ninan;Thomas M Insel;Robert M. Cohen;James M. Cook

  • Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression.

    P. Skolnick;R. T. Layer;P. Popik;G. Nowak

  • Depressed Patients Have Decreased Binding of Tritiated Imipramine to Platelet Serotonin 'Transporter'

    Steven M. Paul;Moshe Rehavi;Phil Skolnick;James C. Ballenger

  • Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.

    I A Paul;G Nowak;R T Layer;P Popik

  • Intra- and interstrain differences in models of “behavioral despair”

    Fengju Bai;Xia Li;Michael Clay;Terry Lindstrom

  • Characterization of benzodiazepine binding sites in cultured cells of neural origin.

    Peter J. Syapin;Phil Skolnick

  • Antidepressant-like actions of an AMPA receptor potentiator (LY392098).

    Xia Li;Joseph P Tizzano;Kelly Griffey;Michael Clay

  • Rapid changes in brain benzodiazepine receptors after experimental seizures

    Steven M. Paul;Phil Skolnick

  • Demonstration of specific high affinity binding sites for [3H] imipramine in human brain.

    Moshe Rehavi;Steven M. Paul;Phil Skolnick;Frederick K. Goodwin

  • 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.

    P Popik;R T Layer;P Skolnick

  • .beta.-Carbolines: synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors

    Michael Cain;Robert W. Weber;Fil Guzman;James M. Cook

  • A Benzodiazepine Receptor—Mediated Model of Anxiety: Studies in Nonhuman Primates and Clinical Implications

    Thomas R. Insel;Philip T. Ninan;Joseph Aloi;David C. Jimerson

Frequent Co-Authors

Anthony S. Basile
Anthony S. Basile National Institutes of Health
Kenner C. Rice
Kenner C. Rice National Institutes of Health
James M. Cook
James M. Cook University of Wisconsin–Milwaukee
Jacqueline N. Crawley
Jacqueline N. Crawley University of California, Davis
Piotr Popik
Piotr Popik Polish Academy of Sciences
John W. Daly
John W. Daly National Institutes of Health
Gabriel Nowak
Gabriel Nowak Jagiellonian University
Paul J. Marangos
Paul J. Marangos National Institutes of Health
Aaron Janowsky
Aaron Janowsky Oregon Health & Science University
Frederick K. Goodwin
Frederick K. Goodwin National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare degrees opens a variety of career pathways beyond traditional medical schools. Many students look for efficient routes to enter or advance within the healthcare field without spending years in traditional classrooms. For example, pursuing a dnp program without clinical hours allows nursing professionals to earn a Doctorate of Nursing Practice degree even if they face obstacles to in-person clinical placements.

Those seeking to join the workforce quickly may consider an lpn accelerated program, which offers a faster path to becoming a Licensed Practical Nurse. For nurses interested in a mental health focus, the fastest psych np program enables swift advancement to Psychiatric Nurse Practitioner roles—meeting a growing need for mental health care providers.

Not all roles in medicine are clinical; administrative careers are vital, too. A health care administration degree online provides the flexibility to build management skills and knowledge, supporting the backbone of health systems.

Best Scientists Citing Phil Skolnick

Trending Scientists